Collins Katrina, Michalova Kvetoslava, de Biase Dario, Ricci Costantino, Tallini Giovanni, Gordetsky Jennifer B, Idrees Muhammad T, Colecchia Maurizio, Ulbright Thomas M, Acosta Andres M
Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Department of Pathology, Charles University, Faculty of Medicine in Plzeň, Bioptical Laboratory, Ltd., Pilsen, Czech Republic.
Histopathology. 2025 Jul;87(1):35-43. doi: 10.1111/his.15422. Epub 2025 Jan 31.
Benign tumours of the rete testis include mostly cystadenomas and adenomas. A subset with tubular or tubulopapillary architecture shows morphological similarities to Sertoli cell tumours; these neoplasms were previously termed "Sertoliform cystadenomas of the rete testis". In the most recent WHO classification, they have been interpreted as Sertoli cell tumours, not otherwise specified (NOS), with pure intra-rete growth, and therefore excluded as an entity. The remaining cystadenomas of the rete testis vaguely resemble tumours of Mullerian origin arising in the ovaries. In this study we analyse benign tumours of the rete testis, including a subset with Sertoliform features.
Benign neoplasms of the rete testis were identified through query of consultation and institutional files. Clinicopathologic data were collected, and available slides were reviewed. Cases were assessed using IHC and three separate DNA sequencing panels. Eleven tumours from patients 32-78 years old were evaluated. Four were classified as Sertoliform adenomas/cystadenomas, displaying tubulo-papillary or tubular/trabecular architecture; all of them were PAX8-positive and lacked nuclear beta-catenin expression. The remaining seven tumours were benign cystadenomas NOS. Genomic analysis was performed successfully in 10/11 tumours (including all Sertoliform adenomas/cystadenomas) and revealed no pathogenic variants in CTNNB1, KRAS, or BRAF.
Sertoliform cystadenomas of the rete testis differ from Sertoli cell tumours NOS, as evidenced by the absence of molecular markers characteristic of Sertoli cell tumours. The remaining benign cystadenomas lack molecular alterations seen in Mullerian tumors of the ovaries.
睾丸网良性肿瘤主要包括囊腺瘤和腺瘤。具有管状或小管乳头状结构的一部分肿瘤在形态学上与支持细胞瘤相似;这些肿瘤以前被称为“睾丸网支持细胞瘤样囊腺瘤”。在最新的世界卫生组织分类中,它们被解释为支持细胞瘤,未另行指定(NOS),具有单纯的睾丸网内生长,因此被排除为一个独立的实体。其余的睾丸网囊腺瘤与卵巢发生的苗勒管源性肿瘤有模糊的相似之处。在本研究中,我们分析了睾丸网良性肿瘤,包括具有支持细胞瘤样特征的一部分肿瘤。
通过查询会诊和机构档案确定睾丸网良性肿瘤。收集临床病理数据,并复查可用的切片。使用免疫组织化学(IHC)和三个独立的DNA测序面板对病例进行评估。对11例年龄在32 - 78岁患者的肿瘤进行了评估。4例被分类为支持细胞瘤样腺瘤/囊腺瘤,显示小管乳头状或管状/小梁状结构;所有这些肿瘤PAX8均为阳性,且缺乏核β-连环蛋白表达。其余7例肿瘤为未另行指定的良性囊腺瘤。10/11例肿瘤(包括所有支持细胞瘤样腺瘤/囊腺瘤)成功进行了基因组分析,结果显示CTNNB1、KRAS或BRAF均无致病性变异。
睾丸网支持细胞瘤样囊腺瘤与未另行指定的支持细胞瘤不同,这一点可通过缺乏支持细胞瘤特征性分子标志物得到证明。其余的良性囊腺瘤缺乏卵巢苗勒管肿瘤中所见的分子改变。